WASHINGTON, D.C. - AdvaMed General Counsel Christopher White issued the following statement expressing concerns about passage of H.R. 1908, The Patent Reform Act of 2007:

"The closely divided vote today in the House of Representatives demonstrates the significant bipartisan opposition to the patent reform plan as currently written. It weakens important patent protections by making patents easier to challenge and cheaper to infringe at a time when America's innovators, manufacturers and workers need stronger patent protections to compete internationally.

"AdvaMed hopes the U.S. Senate will carefully consider this legislation and act to protect America's competitiveness and the future of medical innovation.
"This law contains some of the most sweeping changes America's patent system since the 1950s. AdvaMed urges the Senate to delay further patent legislation until important improvements can be made to protect America's workers, inventors and investors."

More Industry Headlines